FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Federal Register

Emergency Clinical Trial Conduct Guidance

Federal Register notice: FDA makes available a final guidance entitled Considerations for the Conduct of Clinical Trials of Medical Products During Ma...

latest-news-card-1
Medical Devices

MicroVention Transradial Access Catheter Cleared

FDA grants Terumos MicroVention unit 510(k) clearance for its SOFIA EX 5F 115 cm intracranial support catheter for transradial access in addition to t...

Human Drugs

CRL for ARS Pharmaceuticals Neffy

FDA issues a complete response letter to an ARS Pharmaceuticals NDA for neffy, calling for a repeat-dose study.

Human Drugs

Major Disruption Clinical Trial Guidance

FDA publishes a guidance to assist those involved with clinical trials in determining how to proceed during a disaster or public health emergency.

latest-news-card-1
Human Drugs

Industry Fights FDA on Drug Shortage Fixes: Califf

FDA commissioner Robert Califf tells a podcast that drug manufacturers have fought FDA efforts to encourage companies to produce more drugs when there...

latest-news-card-1
Human Drugs

FDA Reviewers Again Nix Intarcia Diabetes Product

FDA medical reviewers tell the Endocrinologic and Metabolic Drugs Advisory Committee that they believe the Intarcia NDA for its ITCA 650 drug/device c...

latest-news-card-1
Human Drugs

Drug Preemption Defense Demanding, Attainable: Attorneys

Two attorneys say their review of drug preemption cases shows that the defense is demanding but can be attained.

latest-news-card-1
Human Drugs

Disc Medicine Gets Fast Track for MWTX-003

FDA grants Disc Medicine a fast-track designation for MWTX-003 and its use for treating patients with polycythemia vera.

latest-news-card-1
Human Drugs

Relmada Depression Trial Shows Promise

Relmada Therapeutics says a Phase 3 trial in Major Depressive Disorder shows that patients treated daily with REL-1017 for up to one year experienced ...

latest-news-card-1
Biologics

Taysha Discontinues Gene Therapy Program

Taysha Gene Therapies says it is discontinuing the development of its gene therapy TSHA-120 program as a treatment for giant axonal neuropathy after r...